Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 58.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.36 | 52 Week High | $8.22 | |||
| Open | $58.36 | 52 Week Low | $3.07 | |||
| Day High | $58.36 | P/E | N/A | |||
| Day Low | $58.36 | EPS | $-1.30 | |||
| Volume | 257 | |||||
